Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse Events

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.12, 2005-01, pp. : 1075-1083

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential for modest differences between sexes in antiretroviral therapy pharmacokinetics and adverse events

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 22, Iss. 11, 2006-11 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

Sex differences in pharmacokinetics and toxicity of antiretroviral therapy

By Umeh Obiamiwe C Currier Judith S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 2, 2006-04 ,pp. : 273-283

Informa Healthcare

Access to resources Recommend Favorite

Visceral Fat as Target of Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-07 ,pp. : 2208-2213

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding and Avoiding Antiretroviral Adverse Events

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1075-1090

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse effects of antiretroviral therapy: focus on bone density

By Viganò Alessandra Mora Stefano

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 199-208

Informa Healthcare

Access to resources Recommend Favorite